dr. saba on scheduling challenges with cisplatin in head and neck cancer
Published 3 years ago • 472 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
1:24
dr. saba on emerging sequencing strategies in head and neck cancer
-
18:37
dr. saba on unique set of challenges caused by covid-19 in head and neck cancer
-
1:49
dr. saba discusses ongoing research in head and neck cancer
-
1:51
dr. saba on treatment deintensification in hpv-related oropharyngeal squamous cell carcinoma
-
2:25
dr. saba on improving cancer detection rates in hnscc
-
3:48
nonsurgical treatment in head and neck cancer: weekly cisplatin - asco recaps head and neck cancer
-
0:54
dr. ferris on a trial testing adu-s100/miw815/pembrolizumab in head and neck cancer
-
2:02
dr. mehanna on the design of the de-escalate trial in hpv head and neck cancer
-
1:09
dr. ferris on immunotherapy in locally advanced head and neck cancer
-
7:25
refining chemoradiation for advanced hnscc
-
6:22
long-term toxicity in hnscc
-
3:05
asco 2020: head and neck cancer highlights
-
2:54
extreme regimen vs. cetuximab cisplatin paclitaxel for recurrent/metastatic head and neck cancer
-
5:54
current perspectives on hpv head and neck cancer
-
10:46
dr. achille manirakiza on head/neck cancer
-
1:03
dr. sabine siesling on mastectomies versus breast conserving surgery
-
![[52] egfr-targeted therapy with c225 and cisplatin in patients with head and neck cancer](https://i.ytimg.com/vi/bmg41rkK9aU/mqdefault.jpg)
3:18
[52] egfr-targeted therapy with c225 and cisplatin in patients with head and neck cancer
-
0:37
stable-mates: sublobar resection vs sabr in high-risk patients with stage i nsclc
-
19:23
exercising to improve the cancer experience: one step at a time part i